据北京的一项新研究,1999年中国抗癌药物的总市场增长了17%,达6.03亿美元,其中抗肺癌、乳腺癌、结肠直肠癌、肝癌、胃癌和食管癌的产品占88%。到2006年这些产品的销售额预计增长到近17亿美元,而在以后的几年中整个抗癌药物领域将增长大约17%。有50多家公司活跃在这个领域,而合 According to a new study in Beijing, the total market for anti-cancer drugs in China increased by 17% in 1999 to reach 603 million U.S. dollars, of which 88% were anti-lung cancer, breast cancer, colorectal cancer, liver cancer, stomach cancer and esophageal cancer. Sales of these products are projected to grow to nearly $ 1.7 billion by 2006, while the overall area of ​​anticancer drugs will grow by about 17% over the next few years. More than 50 companies are active in this area, and together